Atlas Trials

Atorvastatin Use and Portal Hypertension in Patients With Hepatitis B Virus-related Liver Cirrhosis: A Randomized Controlled Trial

Clinical trial NCT05483894 · UNKNOWN

Trial details

NCT number
NCT05483894
Sponsor
Samsung Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis BPortal Hypertension
Start date
2022-08-01
Primary completion
2024-07-31
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.